Kishi Munehiro, Nakamura Mitsutoshi, Nishimine Masayoshi, Ishida Eiwa, Shimada Keiji, Kirita Tadaaki, Konishi Noboru
Department of Pathology and Department of Oral and Maxillofacial Surgery, Nara Medical University, Kashihara, Nara 634-8521, Japan.
Cancer Sci. 2003 Jun;94(6):530-5. doi: 10.1111/j.1349-7006.2003.tb01478.x.
Since loss of heterozygosity (LOH) on the long arm of chromosome 6q is frequently observed in salivary gland carcinomas, we examined 28 salivary gland carcinomas using 24 microsat- ellite markers mapping to 6q15-27 to identify the commonly deleted region that we felt might contain one or more tumor suppressor genes. LOH was detected in at least one locus in 10 of 28 tumors (35.7%). The most frequently deleted regions occurred between D6S1581 and D6S305 (LOH cluster region 1 (LCR1) and between D6S297 and D6S1590 (LCR2). LOH was observed in 60% of adenoid cystic carcinomas (ACC) and in 57.1% of mucoepidermoid carcinomas (MEC), but was not observed in any locus in any other histological subtypes studied. The gene encoding for thrombospondin-2 (TSP-2) is located in LCR2 and 8 of 9 tumors demonstrating LOH in this region also showed significantly decreased TSP-2 expression by immunohistochemistry. As TSP-2 is a potent inhibitor of tumor growth and angiogenesis, we examined whether TSP-2 expression correlated to microvascular angiogenesis in these tumors and discovered that microvessel counts were significantly higher in lesions with decreased TSP-2 expression (P = 0.02). Our results suggest that 6q LOH may be a significant event in salivary gland carcinogenesis, particularly in ACC and MEC, and that the correlated decrease of TSP-2 expression also plays a critical role.
由于在涎腺癌中经常观察到6号染色体长臂上的杂合性缺失(LOH),我们使用24个定位于6q15 - 27的微卫星标记物检测了28例涎腺癌,以确定我们认为可能包含一个或多个肿瘤抑制基因的常见缺失区域。在28个肿瘤中的10个(35.7%)至少一个位点检测到LOH。最常缺失的区域发生在D6S1581和D6S305之间(LOH簇区域1(LCR1))以及D6S297和D6S1590之间(LCR2)。在60%的腺样囊性癌(ACC)和57.1%的黏液表皮样癌(MEC)中观察到LOH,但在研究的任何其他组织学亚型的任何位点均未观察到。血小板反应蛋白 - 2(TSP - 2)的编码基因位于LCR2,在该区域显示LOH的9个肿瘤中有8个通过免疫组织化学也显示TSP - 2表达显著降低。由于TSP - 2是肿瘤生长和血管生成的有效抑制剂,我们检查了TSP - 2表达是否与这些肿瘤中的微血管生成相关,发现TSP - 2表达降低的病变中的微血管计数显著更高(P = 0.02)。我们的结果表明,6q LOH可能是涎腺癌发生中的一个重要事件,特别是在ACC和MEC中,并且TSP - 2表达的相关降低也起关键作用。